Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CVRX NASDAQ:KRMD NASDAQ:MBOT OTCMKTS:RDGL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCVRXCVRx$7.85-0.4%$7.28$4.30▼$18.55$205.29M1.27269,874 shs116,971 shsKRMDKORU Medical Systems$4.22-0.2%$3.71$1.86▼$5.05$195.11M0.47126,133 shs89,982 shsMBOTMicrobot Medical$3.81-4.8%$2.87$0.82▼$4.62$173.53M1.153.06 million shs2.50 million shsRDGLAdvanced Medical Isotope$0.11+0.9%$0.12$0.04▼$0.18$50.59M1.092.95 million shs293,381 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCVRXCVRx0.00%+0.64%-1.38%+18.58%-20.95%KRMDKORU Medical Systems0.00%-3.65%+21.97%+52.35%+72.95%MBOTMicrobot Medical0.00%-1.04%+50.59%+47.67%+302.24%RDGLAdvanced Medical Isotope0.00%+8.06%-7.17%-14.78%-18.10%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCVRXCVRx2.5041 of 5 stars3.41.00.00.03.32.50.6KRMDKORU Medical Systems1.0997 of 5 stars1.52.00.00.02.82.50.6MBOTMicrobot Medical1.3307 of 5 stars3.31.00.00.02.20.00.6RDGLAdvanced Medical IsotopeN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCVRXCVRx 2.86Moderate Buy$14.0078.34% UpsideKRMDKORU Medical Systems 3.00Buy$4.639.60% UpsideMBOTMicrobot Medical 2.50Moderate Buy$9.00136.22% UpsideRDGLAdvanced Medical Isotope 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest RDGL, CVRX, KRMD, and MBOT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/21/2025MBOTMicrobot MedicalZacks ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold8/5/2025CVRXCVRxCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$11.007/7/2025CVRXCVRxWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 8/31/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCVRXCVRx$51.29M4.00N/AN/A$2.22 per share3.54KRMDKORU Medical Systems$33.65M5.80N/AN/A$0.36 per share11.72MBOTMicrobot MedicalN/AN/AN/AN/A$0.67 per shareN/ARDGLAdvanced Medical Isotope$30K1,686.38N/AN/A($0.01) per share-11.13Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCVRXCVRx-$59.97M-$2.10N/AN/AN/A-95.61%-79.31%-40.96%11/4/2025 (Estimated)KRMDKORU Medical Systems-$6.07M-$0.09N/AN/AN/A-12.24%-26.77%-16.81%11/12/2025 (Estimated)MBOTMicrobot Medical-$11.44M-$0.58N/AN/AN/AN/A-76.27%-67.54%11/12/2025 (Estimated)RDGLAdvanced Medical Isotope-$2.91MN/A0.00∞N/A-6,401.92%N/A-139.36%11/11/2025 (Estimated)Latest RDGL, CVRX, KRMD, and MBOT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025MBOTMicrobot Medical-$0.08-$0.10-$0.02-$0.10$1.00 millionN/A8/6/2025Q2 2025KRMDKORU Medical Systems-$0.03$0.01+$0.04N/A$9.46 million$10.20 million8/4/2025Q2 2025CVRXCVRx-$0.52-$0.57-$0.05-$0.57$13.22 million$13.59 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCVRXCVRxN/AN/AN/AN/AN/AKRMDKORU Medical SystemsN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/AN/ARDGLAdvanced Medical IsotopeN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCVRXCVRx0.8511.9910.78KRMDKORU Medical Systems0.012.912.25MBOTMicrobot MedicalN/A12.0612.06RDGLAdvanced Medical IsotopeN/A28.7828.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCVRXCVRx75.27%KRMDKORU Medical Systems58.60%MBOTMicrobot Medical16.30%RDGLAdvanced Medical IsotopeN/AInsider OwnershipCompanyInsider OwnershipCVRXCVRx13.90%KRMDKORU Medical Systems20.60%MBOTMicrobot Medical4.74%RDGLAdvanced Medical Isotope18.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCVRXCVRx16026.15 million22.52 millionOptionableKRMDKORU Medical Systems8046.24 million36.71 millionOptionableMBOTMicrobot Medical2045.55 million43.39 millionOptionableRDGLAdvanced Medical Isotope1454.55 million370.46 millionNot OptionableRDGL, CVRX, KRMD, and MBOT HeadlinesRecent News About These CompaniesAdvanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Down 80.4% in JulyAugust 17, 2025 | marketbeat.comInvestigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo Declined By FDAAugust 14, 2025 | globenewswire.comAdvanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Up 4,877.8% in JulyAugust 2, 2025 | marketbeat.comVivos Inc. Submitted the Investigational Device Exemption (IDE) Application for Human Clinical Trials at Mayo ClinicJuly 14, 2025 | globenewswire.comVivos Inc. Certifies University of Florida Veterinary Hospital for IsoPet® Precision Radionuclide Therapy™May 15, 2025 | globenewswire.comVivos Inc.May 8, 2025 | marketwatch.comVivos Inc. Achieves Record Growth in IsoPet® Animal Cancer Treatments in Q1 2025April 23, 2025 | globenewswire.comVivos Inc. Reports Continued Progress in India Human Clinical Trial for RadioGel® Precision Radionuclide Therapy™April 15, 2025 | globenewswire.comVivos Inc. Reports Encouraging Human Clinical Trial Results and Announces Expansion PlansFebruary 4, 2025 | finance.yahoo.comVivos Inc.’s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics NationwideDecember 27, 2024 | markets.businessinsider.comVivos Inc.'s IsoPet® Division Achieves Exceptional Growth in 2024, Expanding Certified Veterinary Clinics NationwideDecember 26, 2024 | globenewswire.comVivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical TrialDecember 23, 2024 | globenewswire.comVivos Therapeutics eyes positive cash flow as it continues cost-reduction success in Q3November 14, 2024 | proactiveinvestors.comVivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTMOctober 18, 2024 | globenewswire.comVivos Inc. Extended its IsoPet® Precision Radionuclide TherapyTM to ExoticsSeptember 30, 2024 | finance.yahoo.comVivos Inc. (RDGL) Stock Price, News, Quote & History - Yahoo FinanceAugust 25, 2024 | finance.yahoo.comVivos Inc. Provides IDE Submission Status Update – Conversion to Pre-Sub Filing Accepted by the FDAJuly 29, 2024 | globenewswire.comVivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical TrialsJune 28, 2024 | globenewswire.comVivos Inc. (RDGL) Latest Stock News & Headlines - Yahoo FinanceMay 15, 2024 | finance.yahoo.comBarchart’s Hot Penny Stocks Screener Identifies Opportunity in Vivos (RDGL)May 3, 2024 | msn.comVivos Inc. (RDGL)April 27, 2024 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeRDGL, CVRX, KRMD, and MBOT Company DescriptionsCVRx NASDAQ:CVRX$7.85 -0.03 (-0.38%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$7.84 -0.01 (-0.19%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.KORU Medical Systems NASDAQ:KRMD$4.22 -0.01 (-0.24%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$4.22 +0.00 (+0.12%) As of 08/29/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.Microbot Medical NASDAQ:MBOT$3.81 -0.19 (-4.75%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$3.88 +0.07 (+1.84%) As of 08/29/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Advanced Medical Isotope OTCMKTS:RDGL$0.11 +0.00 (+0.91%) As of 08/29/2025 03:31 PM EasternVivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Richland, Washington. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/25 - 08/29 Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
